Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
A Scott Lennox a Department of General Practice and Primary Care,
University of Aberdeen, Aberdeen AB25 2AY, b Department of Medicine and
Therapeutics, University of Aberdeen, c Department of
Computing Science, University of Aberdeen, d Health Economics Research Unit, University of
Aberdeen, e Medicines Monitoring
Unit, Department of Clinical Pharmacology, University of Dundee, Dundee
DD1 9SY
Correspondence to: A Scott Lennox s.lennox{at}abdn.ac.uk
| |
Abstract |
|---|
|
|
|---|
Objectives:
To develop and evaluate, in a primary
care setting, a computerised system for generating tailored letters about smoking cessation.
Design:
Randomised controlled trial.
Setting:
Six general practices in Aberdeen, Scotland.
Participants:
2553 smokers aged 17 to 65.
Interventions:
All participants received a
questionnaire asking about their smoking. Participants subsequently
received either a computer tailored or a non-tailored, standard letter on smoking cessation, or no letter.
Main outcome measures:
Prevalence of validated
abstinence at six months; change in intention to stop smoking in the
next six months.
Results:
The validated cessation rate at six
months was 3.5% (30/857) (95% confidence interval 2.3% to 4.7%) for
the tailored letter group, 4.4% (37/846) (3.0% to 5.8%) for the
non-tailored letter group, and 2.6% (22/850) (1.5% to 3.7%) for the
control (no letter) group. After adjustment for significant covariates, the cessation rate was 66% greater (
4% to 186%; P=0.07) in the non-tailored letter group than that in the no letter group. Among participants who smoked <20 cigarettes per day, the cessation rate in
the non-tailored letter group was 87% greater (0% to 246%; P=0.05)
than that in the no letter group. Among heavy smokers who did not quit,
a 76% higher rate of positive shift in "stage of change"
(intention to quit within a particular period of time) was seen
compared with those who received no letter (11% to 180%; P=0.02). The
increase in cost for each additional quitter in the non-tailored letter
group compared with the no letter group was £89.
Conclusions:
In a large general practice, a
brief non-tailored letter effectively increased cessation rates among
smokers. A tailored letter was not effective in increasing cessation
rates but promoted shift in movement towards cessation ("stage of
change") in heavy smokers. As a pragmatic tool to encourage cessation
of smoking, a mass mailing of non-tailored letters from general
practices is more cost effective than computer tailored letters or no letters.
|
What is already known on this topic
What this paper adds
|
| |
Introduction |
|---|
|
|
|---|
Cigarette smoking continues to be a major preventable source of illness and premature death in Scotland. Intensive, expert-led interventions have relatively high success rates but reach only a small proportion of smokers. The real potential for reducing the national prevalence of smoking lies in the widespread implementation of brief interventions. 1 2
Two studies in North America investigated computer generated
personalised letters as a method of encouraging smoking
cessation.
3 4
The numbers of participants, however, were
small, and in neither study were smokers' claims to have stopped
smoking validated biochemically. We believed that a larger study, with
biochemical validation, was needed on a population with a wider
socioeconomic range.
| |
Methods |
|---|
|
|
|---|
Our randomised controlled trial compared the effect on smoking cessation of a computer tailored letter, a non-tailored letter, and no letter. Ethical approval was obtained from the Grampian joint ethical committee.
Interventions
At the start of the study we sent all participants a
questionnaire asking about their current smoking behaviour, attitudes
to smoking, perception of barriers to quitting, and intention to quit
in the next six months or in one month. After we received their
questionnaire, we sent each participant a computer tailored letter, a
non-tailored letter, or just a letter thanking them for participating
in the study ("no letter").
We developed a computerised system for
generating tailored letters. The system determined the text to be
included in each participant's letter, based on the answers given in
the questionnaire. The phrases and decision rules were devised by experts on smoking cessation and on patient information, in
collaboration with the developers of the software. The experts were
informed by their clinical experience and their knowledge of various
models of behaviour change,5 in particular the "stage of
change" model of smoking cessation.6 How the letters
were tailored is given in more detail on the BMJ 's website.
Non-tailored letter
This was essentially a default tailored
letter produced by scanning a blank questionnaire. To this extent, both
interventions were expert interventions, based on a considerable input
of time, knowledge, and experience.
No letter
We sent control participants a letter thanking
them for their participation and informing them that they would receive material at the end of the study (either a tailored or a non-tailored letter, should either have been shown to be effective).
Recruitment
We recruited participants from smokers aged 17 to 65 years
registered at six general practices in Aberdeen. From the computerised
records of the practices we identified 7427 patients, who were sent a
consent form and a questionnaire to collect information to form the
basis of the tailoring. We sent two reminders at intervals of three weeks.
Assignment and mailing of the letters
After the questionnaires and consent forms were returned,
we randomised the participants individually to the groups using
computer generated random numbers. We mailed materials appropriate to
each group immediately after randomisation.
Follow up
Follow up at six months was by postal questionnaire, with
two reminders at intervals of three weeks. We attempted telephone follow up of non-respondents.
Outcome measures
The main outcome measure was point abstinence at six
months. We validated self reports of smoking cessation by salivary
cotinine assay.7 Participants lost to follow up and those
whose report of cessation could not be confirmed biochemically were
classed as continuing smokers.
Methods of analysis
We used
2 tests to analyse categorical
variables. Differences between groups were assessed by using analysis
of variance. We used multiple logistic regression to assess relations
between outcomes and group membership.11 Analyses were
adjusted for age, sex, level of social deprivation, heaviness of
smoking, time to first cigarette of the day, and initial stage of change.
| |
Results |
|---|
|
|
|---|
Response rates and overall cessation rates
Of the 6155 valid mailings, 2612 responses were valid
(42.4%). A total of 2553 participants did not withdraw, and the follow
up rate was 78.1% (1995/2553). A total of 154 (6.0%) participants
claimed to have stopped smoking after the intervention. Salivary
samples for biochemical validation were obtained from 99 participants.
Eighty nine participants were validated as having stopped smoking,
giving an overall validated cessation rate of 3.5%
(89/2553).
|
|
Characteristics of respondents
The groups were similar in age, sex, level of social
deprivation, and initial stage of change. The percentage of heavy
smokers was higher in the tailored letter group than in the
non-tailored letter group.
Outcomes
Sex, age, and heaviness of smoking were not associated with
cessation, but there was a significant inverse association with level
of social deprivation. Participants whose initial stage of change was
contemplator or preparer were more likely to have stopped than
pre-contemplators, as were participants who had their first cigarette
later in the day (table 1). Validated cessation rates were 3.5%
(30/857; 95% confidence interval 2.3% to 4.7%) in the tailored
letter group, 4.4% (37/846; 3.0% to 5.8%) in the non-tailored letter
group, and 2.6% (22/850; 1.5% to 3.7%) in the control group. After
adjusting for confounding variables, we found that participants
receiving a non-tailored letter were 66% more likely to have quit than
those receiving no letter. After adjustment for confounding variables,
participants who received either a tailored or non-tailored letter were
53% more likely to have quit than those receiving no letter.
20
cigarettes a day and among pre-contemplators there were no differences
between either the tailored letter group or the non-tailored letter
group and the no letter group. On the other hand, contemplators or
preparers who received the non-tailored letter had a higher
cessation rate than those who received no letter.
Among participants who did not stop smoking, heavy smokers who received
the tailored letter were 76% more likely (11% to 180%) to have made
a positive shift in stage of change compared with those who received no letter.
Economic evaluation
Cost effectiveness of the non-tailored letter intervention
Thirty seven of the 846 participants who received a
non-tailored letter stopped smoking, compared with 22 of the 850 participants who received no letter. Costs based on the actual number
of participants recruited indicate that these 15 additional quitters
were gained at a total cost of £464.
| |
Discussion |
|---|
|
|
|---|
The cessation rate of 4.4% is low compared with rates of 19% and 25% in two previous studies of computer generated letters and 21% in a mass media intervention by the Health Education Board for Scotland. 3 4 13 However, our study had methodological strengths: it was carried out on a randomly chosen population who had not actively volunteered to take part in the intervention and had no special motivation to quit; it used an intention to treat analysis, with all participants lost to follow up being classed as continuing smokers; claims of participants to have stopped smoking were biochemically validated; and the tailored and non-tailored letters were created from the same text base.
In contrast, the high rates of cessation in the other studies were based on self reported cessation, and subjects who dropped out were omitted from the calculations of rates of continuing smoking. In some studies the form of the materials used for the control group was very different from that in the tailored intervention. None of these studies used biochemical validation of non-smoking. Contrary to the argument that biochemical validation is unnecessary in brief intervention studies,14 our findings indicate that not validating cessation results in an overestimate of cessation. Furthermore, one study based its success rate on a subgroup of light smokers who had intended to quit smoking.3 If we had used these methods, our rate of cessation would have been 20% or more.
Raw et al summarised evidence on the validated effect of different types of cessation intervention.15 The most effective is nicotine replacement therapy, which increases the rate of cessation by 8% at six months. Brief advice from a doctor increases abstinence at six months by 2-3%. Two validated studies by the British Thoracic Society found that up to three personalised but non-tailored letters, from doctors to outpatients in chest clinics, increased cessation by 2-3%.16 The present study has found that even one short non-tailored letter from a patient's general practice is as effective as these last two brief interventions.
Can we conclude that tailored letters are not effective?
Our hypothesis that tailored letters would be more
effective than non-tailored letters was not supported by the findings.
However, we might consider that our non-tailored letter was in fact
tailored
or at least personalised
to some extent. Although the
non-tailored letter was not tailored to individuals, it was more
personal than a general leaflet giving advice on smoking cessation: it
was in a letter format, with the crest of the local university and the
logo of the patient's general practice, and was ostensibly from "the
practice." This degree of personalisation may account for some of its
effect.16
Cost effectiveness of the non-tailored letter
The cost per quitter of the non-tailored letter is
estimated at between £37 and £89, which compares very favourably with
other cessation interventions.
13 18-20
The cost
effectiveness ratio of the Health Education Board for Scotland's mass
media intervention was between £168 and £369, corresponding to a cost per discounted life year saved of between £304 and £656 (1993 prices).13 However, as pointed out above, this
intervention used self reported quitting. If the true rate of quitting
were lower, the corresponding cost effectiveness would also have been lower.
The potential for implementation of the non-tailored letter
intervention
Intervention by primary care professionals in the form of
brief opportunistic advice increases smoking cessation by about 2-3%
over control intervention,
15 21
but its implementation is
limited by various constraints on health professionals.22 In contrast, the 2% increase in cessation found in the present study
could be widely and easily realised by using the computerised data now
usually held by general practices. Indeed, the quantity and quality of
data on smoking held in general practices are set to improve as
computers become more user friendly. Soon most practices will be
capable of implementing this type of intervention, which would be well
suited to implementation at the level of primary care groups or local
healthcare cooperatives, and which could be part of a national strategy
on smoking cessation. Coordinators from the smoking cessation services
that have recently been set up in all health authorities and boards
could play a central role.
| |
Acknowledgments |
|---|
We thank Martin Pucci and Margaret Taylor for their contribution to the expert group; Steven Porter, Duncan MacIver, and Yvonne McKay for their programming expertise; Annette Hermse, the validation nurse; and the general practitioners and practice managers of participating practices for their cooperation.
Contributors: ASL contributed to the design of the study and to the expert group, led the evaluation, and prepared the manuscript for publication. LMO contributed to the design of the study and to the expert group, carried out some of the analysis, and helped prepare the manuscript for publication. ER contributed to the design of the study, led the development of the computer tailoring system, and helped prepare the manuscript for publication. RR coordinated the development of the computer tailoring system and helped prepare the manuscript for publication. JF contributed to the design of the study and to the expert group. IM was responsible for designing the questionnaire, data collection, and data entry. DS contributed to the design of, carried out, and reported the economic evaluation. PTD advised on statistical aspects of the study design and carried out most of the analysis. ASL, LMO, and ER are the guarantors for the paper.
| |
Footnotes |
|---|
Funding: The Chief Scientist Office, Scottish Executive Health Department, with additional funding from the Engineering and Physical Sciences Research Council. The Health Economics Research Unit is funded by the Chief Scientist Office. The views expressed in this paper are those of the authors and not those of the funding bodies.
Competing interests: None declared.
The full version of this paper
appears on the BMJ's website
| |
References |
|---|
|
|
|---|
| 1. |
Chapman S.
The role of doctors in promoting smoking cessation.
BMJ
1993;
307:
518-519 |
| 2. |
Reid JD, Killoran AJ, McNeill AD, Chambers JS.
Choosing the most effective health promotion options for reducing a nation's smoking prevalence.
Tob Control
1992;
1:
185-197 |
| 3. |
Strecher VJ, Kreuter M, Den Boer D-J, Kobrin S, Hospers HJ, Skinner CS.
The effects of computer tailored smoking cessation messages in family practice settings.
J Fam Pract
1994;
39:
262-270 |
| 4. |
Velicer WF, Prochaska JO, Bellis JM, DiClemente CC, Rossi JS, Fava JL, et al.
An expert system intervention for smoking cessation.
Addict Behav
1993;
18:
269-290 |
| 5. | Reiter E, Robertson R, Osman L. Types of knowledge required to personalise smoking cessation letters. In: Horn W, Shahar Y, Lindberg G, Andreassen S, Wyatt J, eds. Artificial intelligence in medicine: proceedings of the joint European conference on artificial intelligence in medicine and medical decision making (AIMDM '99). Berlin: Springer Verlag, 1999:389-399. |
| 6. |
Prochaska JO, DiClemente CC.
Stages and processes of self-change of smoking: toward an integrative model of change.
J Consult Clin Psychol
1983;
51:
390-395 |
| 7. |
McNeill AD, Jarvis MJ, West R, Russell MAH, Bryant A.
Salivary cotinine as an indicator of cigarette smoking in adults.
Br J Addict
1987;
82:
1355-1360 |
| 8. |
Lennox AS, Bain N, Taylor RJ, McKie L, Donnan PT, Groves J.
Stages of change training for opportunistic smoking intervention by the primary health care team. Part I: randomised controlled trial of the effect of training on patient smoking outcomes and health professional behaviour as recalled by patients.
Health Educ J
1998;
57:
140-149 |
| 9. |
Goldberg DN, Hoffman AM, Farinha MF, Marder DC, Tinson-Mitchem L, Burton D, et al.
Physician delivery of smoking cessation advice based on the stages of change model.
Am J Prev Med
1994;
10:
267-273 |
| 10. |
Slama K, Redman S, Perkins J, Reid AL, Sanson-Fisher RW.
The effectiveness of two smoking cessation programmes for use in general practice: a randomised clinical trial.
BMJ
1990;
300:
1707-1709 |
| 11. | Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley, 1989. |
| 12. |
Oster G, Huse DM, Delea TE, Colditz GA.
Cost effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smoking.
JAMA
1986;
256:
1315-1318 |
| 13. |
Ratcliffe J, Cairns J, Platt S.
Cost effectiveness of a mass media-led anti-smoking campaign in Scotland.
Tob Control
1997;
6:
1-7 |
| 14. |
Velicer WF, Prochaska JO, Rossi JS, Snow MG.
Assessing outcome in smoking cessation studies.
Psychol Bull
1992;
111:
23-41 |
| 15. |
Raw M, McNeill A, West R.
Smoking cessation: evidence based recommendations for the healthcare system.
BMJ
1999;
318:
182-185 |
| 16. |
Research Committee of the British Thoracic Society.
Smoking cessation in patients: two further studies by the British Thoracic Society.
Thorax
1990;
45:
835-840 |
| 17. |
Strecher VJ.
Computer tailored smoking cessation materials: a review and discussion.
Patient Educ Counselling
1999;
36:
107-117 |
| 18. |
Sinclair HK, Silcock J, Bond CM, Lennox AS, Winfield AJ.
The cost effectiveness of intensive pharmaceutical intervention in assisting people to stop smoking.
Int J Pharm Pract
1999;
7:
107-112 |
| 19. |
Butler CC, Rollnick S, Cohen D, Bachmann M, Russell I, Stott N.
Motivational consulting versus brief advice for smokers in general practice: a randomized trial.
Br J Gen Pract
1999;
49:
611-616 |
| 20. |
Phillips CJ, Powle MJ.
Economics of a reduction in smoking; a case study from Heartbeat Wales.
J Epidemiol Comm Health
1993;
47:
15-23 |
| 21. | Fiore MC, Bailey WC, Cohen SJ. Smoking cessation. Rockville, MD: Agency for Health Care Policy and Research, US Department of Health and Human Services, 1996. (Clinical practice guideline 18.) |
| 22. |
Lennox AS, Taylor RJ.
Smoking cessation activity within primary health care in Scotland: present constraints and their implications.
Health Educ J
1995;
54:
48-60 |
(Accepted 8 March 2001)
Read all Rapid Responses